Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Giredestrant in Combination With Phesgo (Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf) Versus Phesgo in Participants With Locally Advanced or Metastatic Breast Cancer (heredERA Breast Cancer) [Phase 3]

View source ↗

Summary

Phase 3 study evaluating Giredestrant with Phesgo versus Phesgo in locally advanced or metastatic breast cancer; the trial is currently active but not recruitin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Or Metastatic Breast Cancer

Drugs mentioned

• Giredestrant (giredestrant)
• PHESGO (PERTUZUMAB, TRASTUZUMAB, AND HYALURONIDASE-ZZXF)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Locally Advanced or Metastatic Breast Cancer | Phase 3 | Status: ACTIVE_NOT_RECRUITING